Side Effects of Drugs Annual : a worldwide yearly survey of new data in adverse drug reactions. Vol. 36 /
The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yea...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Burlington :
Elsevier Science,
2014.
|
Temas: | |
Acceso en línea: | Texto completo Texto completo |
Tabla de Contenidos:
- Front Cover; SIDE EFFECTS OF DRUGS ANNUAL; Copyright; Contributors; Contents; Preface; Special Reviews in SEDA-36; Table of Essays, Annuals 1-35; Mechanistic and Clinical Descriptions of Adverse Drug Reactions; EIDOS; DOTS; References; Definitive (Between-the-Eyes) Adverse Drug Reactions; References; How to Use This Book; THE SCOPE OF THE SIDE EFFECTS OF DRUGS ANNUALS; ALLOCATION OF DRUGS TO CHAPTERS; Abbreviations; Classification of Immunological Reactions; OTHER TYPES OF REACTIONS; References; Classification of Drug Teratogenicity; References; Grades of Adverse Drug Reactions; References.
- Chapter 1
- Central Nervous System Stimulants and Drugs that Suppress AppetiteAMPHETAMINE AND AMPHETAMINE DERIVATES [SEDA-15, 180; SEDA-32, 1; SEDA-33, 1; SEDA-34, 1]; METHYLPHENIDATE [SEDA-15, 2307; SEDA-32, 10; SEDA-33, 7; SEDA-34, 5]; METHYLXANTHINES; SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITORS ATOMOXETINE [SEDA-33, 6; SEDA-34, 4]; VIGILANCE PROMOTING DRUGS; DRUGS THAT SUPPRESS APPETITE [SEDA-30, 7; SEDA-32, 16; SEDA-33, 13; SEDA-34, 8]; PARASYMPATHOMIMETICS [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; References; Chapter 2
- Antidepressant Drugs; GENERAL.
- SELECTIVE SEROTONIN REUPTAKE INHIBITORS [SED-15, 3109 SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35, 30]; SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; OTHER ANTIDEPRESSANTS; References; Chapter 3
- Lithium; LITHIUM TOXICITY; References; Chapter 4
- Drugs of Abuse; CANNABINOIDS; COCAINE; ECSTASY (3,4-METHYLENEDIOXYMETAMFETAMINE); References; Chapter 5
- Hypnosedatives and Anxiolytics; BENZODIAZEPINES [SED-15, 429; SEDA-31, 57; SEDA-32, 75; SEDA-33, 71; SEDA-34, 45]; HYPNOSEDATIVES AND BENZODIAZEPINE-LIKE DRUGS [SED-15, 3710; SEDA-33, 78.
- SEDA-34, 47]References; Chapter 6
- Antipsychotic Drugs; GENERAL [SED-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51; SEDA-35, 85]; INDIVIDUAL DRUGS; References; Chapter 7
- Antiepileptic Drugs; RX PHARMACOGENOMICS AND ANTIEPILEPTIC MEDICATIONS; GENERAL; COMPARATIVE STUDIES; ETHOSUXIMIDE; References; Chapter 8
- Opioid Analgesics and Narcotic Antagonists; RX: OPIOID ABUSE EPIDEMIC AND THE ROLE OF TAKE-HOME NALOXONE; ALFENTANIL [SED-15, 72; SEDA-33, 209; SEDA-34, 152; SEDA-35, 173]; CODEINE [SED-15, 880; SEDA-33, 209; SEDA-34, 152; SEDA-35, 174]; DEXTROMETROPHAN [SED-15, 1088.
- Seda-33, 210 seda-34, 153; seda-35, 174]; diamorphine [sed-15, 1096; seda-33, 210; seda-34, 153; seda-35, 175]; dihydrocodeine [sed-15, 1125; seda-33, 211; seda-34, 154; seda-35, 175]; fentanyl [sed-15, 1346; seda-33, 211; seda-34, 154; seda-35, 176]; hydrocodone [sed-15, 1702; seda-34, 156; seda-35, 177]; methadone [sed-15, 2270; seda-33, 214; seda-34, 157; seda-35, 177]; morphine [sed-15, 2386; seda-33, 216; seda-34, 159; seda-35, 181]; oxycodone [sed-15, 2651; seda-33, 219; seda-34, 161; seda-35, 182]; papaverine [sed-15, 2678; seda-33, 221; seda-34, 162.